Privi Speciality Chemicals has announced a record-breaking second quarter and first half for FY27. The company achieved its highest ever quarterly revenue of INR773.16 crore, a 13.9% year-on-year increase, and EBITDA of INR212.49 crore, up 16.66%. Profit after tax reached INR117.03 crore, growing 24.61%. Reflecting confidence, the board declared its first interim dividend of INR5 per share.
Privi Speciality Chemicals Achieves Record Financial Performance
Privi Speciality Chemicals Limited has reported outstanding results for the second quarter and first half of the financial year 2026-27, marking its strongest ever quarterly performance. Despite facing global headwinds, the company achieved record sales and profitability.
Q2 FY27 Financial Highlights
In the second quarter of FY27, Privi Speciality Chemicals posted a total revenue of INR773.16 crore, representing a significant 13.9% increase compared to the same period last year. The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at INR212.49 crore, up by 16.66% year-on-year. Profit After Tax (PAT) for the quarter was INR117.03 crore, showing a growth of 24.61% over the previous year.
H1 FY27 Performance
For the first half of FY27, the company’s strong operating momentum continued. Total income reached INR773.16 crore, while EBITDA was INR212.49 crore. The profit after tax for the first half amounted to INR201 crore, an increase of approximately 29% compared to the prior year.
Operational Strengths and Expansion
The company’s performance is attributed to its robust business model, strong customer relationships, and strategic investments in manufacturing capabilities. The focus remains on building a more resilient and differentiated specialty aroma chemical business. Capacity expansion through the Phase 1 program, increasing installed capacity from 48,000 to 54,000 metric tons per annum, has been completed. The company is also progressing with implementing new molecules and advancing its joint venture with Jeevadan.
Dividend Declaration
Demonstrating confidence in its business outlook and commitment to shareholder value, the Board of Directors has declared the company’s first-ever interim dividend of INR5 per share of face value INR10 for the financial year 2026-27.
Balance Sheet Strength
As of September 30, 2026, Privi’s balance sheet remains strong, supported by healthy financial returns and prudent leverage. The Return on Capital Employed (ROCE) stood at 24.30%, an improvement of 216 basis points year-on-year. The Return on Equity (ROE) increased by 134 basis points to 26.34%. The net debt-to-EBITDA ratio was 1.07x, and net debt to equity was 0.51x. Net debt was INR814.51 crore, and the working capital cycle improved to less than 100 days.
Future Outlook
Privi Speciality Chemicals is focused on profitable growth and cash generation, allocating capital towards capacity expansion, new specialty products, and operational improvements. The company reiterates its confidence in achieving a 20% growth in the coming years and is on track to meet its 5K:1K plus vision.
Source: BSE
